Mixed connective tissue disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
===Prevalence=== | ===Prevalence=== | ||
* Population-based epidemiology study in Norway estimated the point prevalence of adult-onset MCTD to be 3.8 per 100,000 individuals.<ref name="pmid27421219">{{cite journal |vauthors=Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø |title=Mixed connective tissue disease |journal=Best Pract Res Clin Rheumatol |volume=30 |issue=1 |pages=95–111 |date=February 2016 |pmid=27421219 |doi=10.1016/j.berh.2016.03.002 |url=}}</ref> | |||
* A nationwide study in Japan showed the prevalence of mixed connective tissue disease was 2.7 per 100,000.<ref name="pmid22466167">{{cite journal |vauthors=Kanno A, Nishimori I, Masamune A, Kikuta K, Hirota M, Kuriyama S, Tsuji I, Shimosegawa T |title=Nationwide epidemiological survey of autoimmune pancreatitis in Japan |journal=Pancreas |volume=41 |issue=6 |pages=835–9 |date=August 2012 |pmid=22466167 |doi=10.1097/MPA.0b013e3182480c99 |url=}}</ref> | |||
===Mortality rate=== | ===Mortality rate=== | ||
*In MCTD, the [[mortality rate]] is nearly 10.4% over the period of 13-15 years.<ref name="pmid24433611">{{cite journal |vauthors=Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA |title=Cardiac involvement in mixed connective tissue disease: a systematic review |journal=Int. J. Cardiol. |volume=171 |issue=3 |pages=326–30 |date=February 2014 |pmid=24433611 |doi=10.1016/j.ijcard.2013.12.079 |url=}}</ref> | *In MCTD, the [[mortality rate]] is nearly 10.4% over the period of 13-15 years.<ref name="pmid24433611">{{cite journal |vauthors=Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA |title=Cardiac involvement in mixed connective tissue disease: a systematic review |journal=Int. J. Cardiol. |volume=171 |issue=3 |pages=326–30 |date=February 2014 |pmid=24433611 |doi=10.1016/j.ijcard.2013.12.079 |url=}}</ref> | ||
Revision as of 15:51, 18 April 2018
|
Mixed connective tissue disease Microchapters |
|
Differentiating Mixed connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mixed connective tissue disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mixed connective tissue disease epidemiology and demographics |
|
FDA on Mixed connective tissue disease epidemiology and demographics |
|
on Mixed connective tissue disease epidemiology and demographics |
|
Mixed connective tissue disease epidemiology and demographics in the news |
|
Blogs onMixed connective tissue disease epidemiology and demographics |
|
Directions to Hospitals Treating Mixed connective tissue disease |
|
Risk calculators and risk factors for Mixed connective tissue disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of mixed connective tissue disease is approximately 2.7 per 100,000 individuals per year.[1]
Prevalence
- Population-based epidemiology study in Norway estimated the point prevalence of adult-onset MCTD to be 3.8 per 100,000 individuals.[2]
- A nationwide study in Japan showed the prevalence of mixed connective tissue disease was 2.7 per 100,000.[3]
Mortality rate
- In MCTD, the mortality rate is nearly 10.4% over the period of 13-15 years.[4]
Age
- Mixed connective tissue disease is usually diagnosed during childhood. It usually starts between 2 and 16 years of age (mean age of 11 years old).[1]
Race
- MCTD is more frequent in the black population and among Asians.[5]
Gender
- Female are more commonly affected by mixed connective tissue disease than male. The female to male ratio is approximately 10 to 1.[6]
References
- ↑ 1.0 1.1 Latuśkiewicz-Potemska J, Zygmunt A, Biernacka-Zielińska M, Stańczyk J, Smolewska E (October 2013). "Mixed connective tissue disease presenting with progressive scleroderma symptoms in a 10-year-old girl". Postepy Dermatol Alergol. 30 (5): 329–36. doi:10.5114/pdia.2013.38365. PMC 3858664. PMID 24353496.
- ↑ Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø (February 2016). "Mixed connective tissue disease". Best Pract Res Clin Rheumatol. 30 (1): 95–111. doi:10.1016/j.berh.2016.03.002. PMID 27421219.
- ↑ Kanno A, Nishimori I, Masamune A, Kikuta K, Hirota M, Kuriyama S, Tsuji I, Shimosegawa T (August 2012). "Nationwide epidemiological survey of autoimmune pancreatitis in Japan". Pancreas. 41 (6): 835–9. doi:10.1097/MPA.0b013e3182480c99. PMID 22466167.
- ↑ Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA (February 2014). "Cardiac involvement in mixed connective tissue disease: a systematic review". Int. J. Cardiol. 171 (3): 326–30. doi:10.1016/j.ijcard.2013.12.079. PMID 24433611.
- ↑ Missounga L, Ba JI, Nseng Nseng Ondo IR, Nziengui Madjinou M, Malekou D, Mouendou Mouloungui EG, Nzengue EE, Boguikouma JB, Kombila M (2017). "[Mixed connective tissue disease: prevalence and clinical characteristics in African black, study of 7 cases in Gabon and review of the literature]". Pan Afr Med J (in French). 27: 162. doi:10.11604/pamj.2017.27.162.12572. PMC 5567953. PMID 28904690. Vancouver style error: initials (help)
- ↑ Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL (December 2016). "Epidemiology of Mixed Connective Tissue Disease, 1985-2014: A Population-Based Study". Arthritis Care Res (Hoboken). 68 (12): 1843–1848. doi:10.1002/acr.22872. PMC 5426802. PMID 26946215.